Henderson et al., analyzed the expression of CD44 by immunohistochemistry in a series of 23 soft tissue sarcomas (8 liposarcomas, 4 myxofibrosarcoma, 4 undifferentiated pleiomorphic sarcomas, 1 alveolar soft parts sarcoma, 1 extraskeletal mesenchymal chondrosarcoma, 1 leiomyosarcoma, 1 malignant peripheral nerve sheath tumor, 1 extraskeletal osteosarcoma, 1 synovial sarcoma, and 1 primitive neuro-ectodermal tumor. The gene discussed is CD44; the disease is malignant peripheral nerve sheath tumor.